P R Burkhard

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi request reprint Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists
    Judit Horvath
    Department of Neurology, University Hospital, Geneva, Switzerland
    Mov Disord 19:656-62. 2004
  2. ncbi request reprint Acute and subacute drug-induced movement disorders
    Pierre R Burkhard
    Movement Disorders Unit, Department of Neurology, Geneva University Hospitals, Switzerland Electronic address
    Parkinsonism Relat Disord 20:S108-12. 2014
  3. pmc A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis
    Saskia Ditisheim
    Gastroenterology and Hepatology, University Hospitals and Faculty of Medicine, 4, rue Gabrielle Perret Gentil, 1211 Geneva, Switzerland
    BMC Gastroenterol 11:134. 2011
  4. ncbi request reprint Plant-induced seizures: reappearance of an old problem
    P R Burkhard
    Department of Neurology, University Hospital, CH 1211 Geneva 14, Switzerland
    J Neurol 246:667-70. 1999
  5. ncbi request reprint [Unusual causes of gait disorders]
    Pierre R Burkhard
    Clinique et Policlinique de Neurologie, Hopital Cantonal, Hopitaux Universitaires de Geneve
    Rev Med Suisse Romande 123:63-8. 2003
  6. ncbi request reprint Cerebrospinal fluid tau and Abeta42 concentrations in healthy subjects: delineation of reference intervals and their limitations
    Pierre R Burkhard
    Department of Neurology, Cantonal Hospital, Geneva, Switzerland
    Clin Chem Lab Med 42:396-407. 2004
  7. ncbi request reprint [Current treatment of Parkinson's disease: problems and controversies]
    P R Burkhard
    Service de neurologie Département Neuclid HUG, 1211 Geneve 14
    Rev Med Suisse 1:1214, 1216-9. 2005
  8. ncbi request reprint Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration
    Pierre R Burkhard
    Department of Neurology, University Hospital, Geneva, Switzerland
    Arch Neurol 60:521-8. 2003
  9. ncbi request reprint [Quiz case]
    Pierre R Burkhard
    Clinique et Policlinique de Neurologie, Hopital Cantonal, Hopitaux Universitaire de Geneve
    Rev Med Suisse Romande 123:75-6. 2003
  10. ncbi request reprint Assessing cerebrospinal fluid rhinorrhea: a two-dimensional electrophoresis approach
    P R Burkhard
    Department of Neurology, University Hospital, Geneva, Switzerland
    Electrophoresis 22:1826-33. 2001

Collaborators

Detail Information

Publications62

  1. ncbi request reprint Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists
    Judit Horvath
    Department of Neurology, University Hospital, Geneva, Switzerland
    Mov Disord 19:656-62. 2004
    ..Therefore, until more is known about the true prevalence of this side effect, we propose that an assessment of cardiac function be performed before and in the course of a long-term therapy with ergot derivative dopamine agonists...
  2. ncbi request reprint Acute and subacute drug-induced movement disorders
    Pierre R Burkhard
    Movement Disorders Unit, Department of Neurology, Geneva University Hospitals, Switzerland Electronic address
    Parkinsonism Relat Disord 20:S108-12. 2014
    ....
  3. pmc A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis
    Saskia Ditisheim
    Gastroenterology and Hepatology, University Hospitals and Faculty of Medicine, 4, rue Gabrielle Perret Gentil, 1211 Geneva, Switzerland
    BMC Gastroenterol 11:134. 2011
    ..Hepatic encephalopathy (HE) is a frequent and severe complication of cirrhosis. A single determination of ammonia in venous blood correlates poorly with neurological symptoms. Thus, a better biological marker is needed...
  4. ncbi request reprint Plant-induced seizures: reappearance of an old problem
    P R Burkhard
    Department of Neurology, University Hospital, CH 1211 Geneva 14, Switzerland
    J Neurol 246:667-70. 1999
    ..Our three cases strongly support the concept of plant-related toxic seizure. Nowadays the wide use of these compounds in certain unconventional medicines makes this severe complication again possible...
  5. ncbi request reprint [Unusual causes of gait disorders]
    Pierre R Burkhard
    Clinique et Policlinique de Neurologie, Hopital Cantonal, Hopitaux Universitaires de Geneve
    Rev Med Suisse Romande 123:63-8. 2003
    ....
  6. ncbi request reprint Cerebrospinal fluid tau and Abeta42 concentrations in healthy subjects: delineation of reference intervals and their limitations
    Pierre R Burkhard
    Department of Neurology, Cantonal Hospital, Geneva, Switzerland
    Clin Chem Lab Med 42:396-407. 2004
    ..We propose that the issue of defining reference limits for both cerebrospinal fluid tau and Abeta42 may ultimately be settled by studying large numbers of autopsy-proven neurologically intact individuals only...
  7. ncbi request reprint [Current treatment of Parkinson's disease: problems and controversies]
    P R Burkhard
    Service de neurologie Département Neuclid HUG, 1211 Geneve 14
    Rev Med Suisse 1:1214, 1216-9. 2005
    ..After initial therapeutic enthusiasm, we are now at a time of problems and controversies...
  8. ncbi request reprint Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration
    Pierre R Burkhard
    Department of Neurology, University Hospital, Geneva, Switzerland
    Arch Neurol 60:521-8. 2003
    ..The clinical, neuroradiological, and biological characteristics of the so-called acquired hepatocerebral degeneration have not yet been fully determined and its frequency remains largely uncertain...
  9. ncbi request reprint [Quiz case]
    Pierre R Burkhard
    Clinique et Policlinique de Neurologie, Hopital Cantonal, Hopitaux Universitaire de Geneve
    Rev Med Suisse Romande 123:75-6. 2003
  10. ncbi request reprint Assessing cerebrospinal fluid rhinorrhea: a two-dimensional electrophoresis approach
    P R Burkhard
    Department of Neurology, University Hospital, Geneva, Switzerland
    Electrophoresis 22:1826-33. 2001
    ..These preliminary results suggest that a 2-DE-based multimarker approach is a valid, sensitive, and specific method to assess the presence of CSF in occult rhinorrhea...
  11. ncbi request reprint Sub-acute delayed failure of subthalamic DBS in Parkinson's disease: the role of micro-lesion effect
    C Granziera
    Department of Neurology, Centre Hospitalier, Universitaire Vaudois, CHUV, Rue du Bugnon, 46, 1011 Lausanne, Switzerland
    Parkinsonism Relat Disord 14:109-13. 2008
    ..To study delayed failure after subthalamic nucleus (STN) deep brain stimulation in Parkinson's disease (PD) patients...
  12. ncbi request reprint Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years
    H Russmann
    Department of Neurology, University Hospital CHUV, Lausanne, Switzerland
    Neurology 63:1952-4. 2004
    ..Their activities of daily living and axial subscores worsened, particularly in those with preoperative gait difficulties...
  13. ncbi request reprint Carbamazepine encephalopathy masquerading as Creutzfeldt-Jakob disease
    J Horvath
    Department of Neurology, Geneva University Hospitals and Medical School, Geneva, Switzerland
    Neurology 65:650-1. 2005
  14. ncbi request reprint L-dopa-induced dyskinesia improvement after STN-DBS depends upon medication reduction
    H Russmann
    Department of Neurology, HUG, Geneva, Switzerland
    Neurology 63:153-5. 2004
    ..03). These data support dopaminergic stimulation and striatal desensitization as major determinants of LID in PD...
  15. ncbi request reprint Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation
    C Wider
    Department of Neurology, CHUV, Rue du Bugnon, 1011 Lausanne, Switzerland
    Parkinsonism Relat Disord 14:114-9. 2008
    ..To describe the long-term outcome in 50 consecutive advanced Parkinson's disease (PD) patients treated with subthalamic nucleus deep brain stimulation (STN-DBS)...
  16. ncbi request reprint CSF detection of the 14-3-3 protein in unselected patients with dementia
    P R Burkhard
    Department of Neurology, University Hospital, Geneva, Switzerland
    Neurology 56:1528-33. 2001
    ..To determine the usefulness of the 14-3-3 test in patients with dementia of various causes...
  17. ncbi request reprint How do parkinsonian signs return after discontinuation of subthalamic DBS?
    P Temperli
    Department of Neurology, Centre Hospitalier Universitaire Vaudois, Lausanne CHUV, Switzerland
    Neurology 60:78-81. 2003
    ..To study the reappearance of the clinical signs of PD when subthalamic nucleus (STN) deep brain stimulation (DBS) was turned off...
  18. doi request reprint Differentiation between Parkinson disease and other forms of Parkinsonism using support vector machine analysis of susceptibility-weighted imaging (SWI): initial results
    S Haller
    Service Neuro Diagnostique et Neuro Interventionnel DISIM, Hopitaux Universitaires de Geneve, Rue Gabrielle Perret Gentil 4, 1211, Geneve 14, Switzerland
    Eur Radiol 23:12-9. 2013
    ..To diagnose Parkinson disease (PD) at the individual level using pattern recognition of brain susceptibility-weighted imaging (SWI)...
  19. ncbi request reprint Levodopa-induced ocular dyskinesia in Parkinson's disease
    H Grötzsch
    Department of Neurology, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
    Eur J Neurol 14:1124-8. 2007
    ....
  20. ncbi request reprint Is cerebral autoregulation impaired in Parkinson's disease? A transcranial Doppler study
    N Vokatch
    Department of Neurology, Geneva University Hospitals and Medical School, Switzerland
    J Neurol Sci 254:49-53. 2007
    ..These results provide evidence of an impaired cerebral autoregulation in PD patients which appears independent of dopaminergic treatment...
  21. ncbi request reprint [Recurrent encephalopathy after small bowel resection. Implication of D-lactate]
    P H Lalive
    Clinique et Policlinique de Neurologie, Hopital Cantonal Universitaire de Geneve, Suisse
    Rev Neurol (Paris) 157:679-81. 2001
    ..Diagnosis is confirmed by appropriate dosages. We discussed the possible mechanisms leading to confusional episodes...
  22. doi request reprint Naloxone-responsive acute dystonia and parkinsonism following general anaesthesia
    I A Iselin-Chaves
    Department of Anaesthesiology, Geneva University Hospitals and Faculty of Medicine, Geneve, Switzerland
    Anaesthesia 64:1359-62. 2009
    ....
  23. ncbi request reprint [Wilson's disease: Clinical presentations]
    C Chilcott-Lauber
    Service de médecine communautaire, Département de médecine communautaire, Geneve
    Rev Med Suisse 1:2018, 2020-2. 2005
    ..We also briefly review the pathophysiology of the illness, discuss the latest guidelines for diagnosis and treatment and outline the recent genetic discoveries...
  24. ncbi request reprint [Autoantibodies in neurological diseases: clinical implications]
    P H Lalive
    Départment des neurosciences cliniques, HUG, Geneve
    Rev Med Suisse 5:942-4, 946-8, 950. 2009
    ..The detection of some of these autoantibodies may help the clinician to establish a definite diagnosis which may further facilitate the therapeutic decision...
  25. ncbi request reprint Neuropathology of a case of dopa-responsive dystonia associated with a new genetic locus, DYT14
    H Grötzsch
    Department of Neurology, University Hospital, Geneva, Switzerland
    Neurology 58:1839-42. 2002
    ..Dopa-responsive dystonia has a unique neuropathologic signature that seems to be independent of its genotype...
  26. ncbi request reprint Changes of the cortex proteome and Apolipoprotein E in transgenic mouse models of Alzheimer's Disease
    O Carrette
    Neuroproteomics Group, Department of Structural Biology and Bioinformatics, Geneva University, Faculty of Medicine, Geneva, Switzerland
    J Chromatogr B Analyt Technol Biomed Life Sci 840:1-9. 2006
    ..These proteins and their modification probably play a role in the amyloid aggregate formation in these mice...
  27. ncbi request reprint Phenotypic heterogeneity of dopa-responsive dystonia in monozygotic twins
    H Grötzsch
    Neurology Department, University Hospital, Geneva, Switzerland
    Neurology 62:637-9. 2004
    ..The contribution of environmental factors appeared minimal. Intrafamilial variability of DRD phenotype may be related to yet unknown non-Mendelian epigenetic or proteomic factors...
  28. ncbi request reprint Bilateral optic ischemic neuropathy related to chronic hepatitis C-associated anticardiolipin antibodies
    M Sinnreich
    Department of Neurology, University Hospital, Geneva, Switzerland
    Eur Neurol 49:243-5. 2003
  29. doi request reprint Individual detection of patients with Parkinson disease using support vector machine analysis of diffusion tensor imaging data: initial results
    S Haller
    Service Neuro diagnostique et Neuro interventionnel, Département de l Imagerie et Science de l Information Médical, University Hospitals of Geneva, Geneva, Switzerland
    AJNR Am J Neuroradiol 33:2123-8. 2012
    ..We performed a pattern-recognition analysis based on DTI data to detect subjects with PD at the individual level...
  30. doi request reprint Restless legs syndrome: an early manifestation of Huntington's disease?
    E Savva
    Department of Neurology, Geneva University Hospitals and Medical School, Switzerland
    Acta Neurol Scand 119:274-6. 2009
    ..Far from being uniform, Huntington's disease (HD)'s phenotype encompasses a large variety of motor and non-motor symptoms which occur in various combinations in individual patients...
  31. ncbi request reprint ECG artifact due to deep brain stimulation
    W A Martin
    Division of Cardiology Hopitaux Universitaires de Genève, CH 1211 14, Geneva, Switzerland
    Lancet 361:1431. 2003
  32. ncbi request reprint Bullous pemphigoid antigen 1 isoforms: potential new target autoantigens in multiple sclerosis?
    E Laffitte
    Department of Dermatology, University Hospital, Geneva, Switzerland
    Br J Dermatol 152:537-40. 2005
    ..The simultaneous occurrence of bullous pemphigoid (BP) and multiple sclerosis (MS), two autoimmune diseases involving the skin and the central nervous system (CNS), respectively, has been described...
  33. ncbi request reprint Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease?
    Aline Gronchi-Perrin
    Vaud Geneva Deep Brain Stimulation Program for Movement Disorders, CHUV, Lausanne, Switzerland
    Mov Disord 21:1465-8. 2006
    ..This observation highlights the impact of the method used on obtained results when assessing the effects of STN DBS...
  34. ncbi request reprint Clinical assessment of motor function: a processes oriented instrument based on a speed-accuracy trade-off paradigm
    Blaise Christe
    Neuropsychology Unit, Department of Neurology, Geneva University Hospitals and Medical School, Switzerland
    Behav Neurol 18:19-29. 2007
    ....
  35. doi request reprint Rhinorrhea and olfaction in Parkinson disease
    Basile N Landis
    Neurology 71:1041-2; author reply 1042. 2008
  36. ncbi request reprint Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy
    Laurent Spahr
    Gastroenterology and Hepatology, University Hospital, Geneva, Switzerland
    Metab Brain Dis 17:399-413. 2002
    ..Clinical observations are presented regarding the evolution of parkinsonian signs in various situations...
  37. ncbi request reprint TNF-alpha and psychologically stressful events in healthy subjects: potential relevance for multiple sclerosis relapse
    Patrice H Lalive
    Department of Neurology, University Hospital of Geneva, Switzerland
    Behav Neurosci 116:1093-7. 2002
    ....
  38. ncbi request reprint Identification of post-mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration
    Pierre Lescuyer
    Biomedical Proteomics Research Group, Clinical Chemistry Laboratory, Geneva University Hospital, Switzerland
    Proteomics 4:2234-41. 2004
    ..We recently showed that H-FABP, a protein highly homologous to E-FABP and A-FABP identified in this study, is a potential marker of Creutzfeldt-Jakob disease and stroke...
  39. doi request reprint Restless arms
    Judit Horvath
    Department of Neurology, University Hospital of Geneva, Geneva, Switzerland
    Lancet 371:530. 2008
  40. ncbi request reprint Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation
    Christian Wider
    Department of Neurology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland
    Arch Neurol 63:951-5. 2006
    ..Long-duration response (LDR) to levodopa is supposed to decrease with Parkinson disease (PD) progression, but direct observation of this response in advanced PD has never been performed...
  41. ncbi request reprint Fulminant Lewy body disease
    Isabelle Momjian-Mayor
    Department of Neurology, Geneva University Hospitals and Medical School, Geneva, Switzerland
    Mov Disord 21:1748-51. 2006
    ....
  42. ncbi request reprint Identification of brain cell death associated proteins in human post-mortem cerebrospinal fluid
    Jennifer A Burgess
    Biomedical Proteomics Research Group, Department of Structural Biology and Bioinformatics, Faculty of Medicine, University of Geneva, Geneva, Switzerland
    J Proteome Res 5:1674-81. 2006
    ..Interestingly, among the proteins specifically identified in the post-mortem CSF, several have been previously described as biochemical markers of brain damage...
  43. ncbi request reprint ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke
    Laure Allard
    Biomedical Proteomics Research Group, Central Clinical Chemistry Laboratory, Geneva University Hospital, Geneva, Switzerland
    Proteomics 4:2242-51. 2004
    ..It requires further investigation in a large cohort of patients...
  44. ncbi request reprint A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt-Jakob disease
    Elisabeth Guillaume
    Biomedical Proteomics Research Group, Central Clinical Chemistry Laboratory, Geneva University Hospital, 24 Rue Micheli du Crest, CH 1211 Geneva 14, Switzerland
    Proteomics 3:1495-9. 2003
    ..05) increased in all tested samples. H-FABP detection could therefore be helpful as a blood screening test for a pre-mortem diagnosis of the disease and also to prevent the risk of iatrogenic transmission of CJD through blood transfusion...
  45. ncbi request reprint [Parkinson disease: description of an interdisciplinary program of functional group rehabilitation]
    Dominique Monnin
    Clinique de Rééducation, Hopital Cantonal, Hopitaux Universitaires de Geneve
    Rev Med Suisse Romande 123:257-61. 2003
    ..In our opinion, our data emphasizes the usefulness of specific neurorehabilitation programs in the global management of Parkinson's disease...
  46. ncbi request reprint Skull base cerebrospinal fluid fistula: a novel detection method based on two-dimensional electrophoresis
    Alma Ricchetti
    Rhinology Unit, Department of Otorhinolaryngology Head and Neck Surgery, Geneva University Hospital, 24, rue Micheli du Crest 1211 Genève 14, Switzerland
    Head Neck 26:464-9. 2004
    ..The detection of the presence of cerebrospinal fluid (CSF) in nasal secretions contaminated with blood and mucus remains a challenging clinical problem...
  47. ncbi request reprint Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease
    Jean Charles Sanchez
    Biomedical Proteomics Research Group, Central Clinical Chemistry Laboratory, Geneva University Hospital, Switzerland
    Proteomics 4:2229-33. 2004
    ..05) in all tested samples (n = 8). We conclude that the analysis of cystatin C levels in CSF could be useful as a pre-mortem indicator of the disease...
  48. doi request reprint Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags
    Loïc Dayon
    Biomedical Proteomics Group, Department of Structural Biology and Bioinformatics, Faculty of Medicine, University of Geneva, Geneva, Switzerland
    Anal Chem 80:2921-31. 2008
    ..ELISA for these proteins confirmed their elevated concentration in PM CSF. This work demonstrates the validity and robustness of the tandem mass tag (TMT) approach for quantitative MS-based proteomics...
  49. ncbi request reprint Voluntarily simulated tremor in normal subjects
    Pierre R Burkhard
    Parkinson s Institute, Sunnyvale, California, USA
    Neurophysiol Clin 32:119-26. 2002
    ..It is therefore possible that all tremors are somehow influenced by the same central oscillators which may become disinhibited and clinically apparent in pathological conditions such as PD or ET...
  50. ncbi request reprint [Kinesiologic analysis of gait and abnormal movements]
    Yves Blanc
    Laboratoire de cinésiologie, Clinique de Neurologie, Hôpitaux universitaires de Genève 24 rue Michelli du Crest, 1211 Geneve
    Rev Med Suisse Romande 123:327-33. 2003
    ..In the present article, we review the particular features of these measurement tools and the clinical usefulness of their routine use illustrated by case reports...
  51. doi request reprint Brueghel syndrome as a new manifestation of HIV encephalopathy
    Jacques Wicki
    Eur Neurol 60:107-8. 2008
  52. ncbi request reprint Gait assessment in Parkinson's disease: toward an ambulatory system for long-term monitoring
    Arash Salarian
    Laboratory of Movement Analysis and Measurement LMAM, Swiss Federal Institute of Technology EPFL, Lausanne, Switzerland
    IEEE Trans Biomed Eng 51:1434-43. 2004
    ..We concluded that our method provides a simple yet effective way of ambulatory gait analysis in PD patients with results confirming those obtained from much more complex and expensive methods used in gait labs...
  53. ncbi request reprint Fatty acid binding protein as a serum marker for the early diagnosis of stroke: a pilot study
    Catherine G Zimmermann-Ivol
    Biomedical Proteomics Research Group, Clinical Chemistry Laboratory, Geneva University Hospital, Geneva, Switzerland
    Mol Cell Proteomics 3:66-72. 2004
    ..H-FABP appears to be a valid serum biomarker for the early diagnosis of stroke. Further studies on large cohorts of patients are warranted...
  54. ncbi request reprint Quantification of tremor and bradykinesia in Parkinson's disease using a novel ambulatory monitoring system
    Arash Salarian
    Laboratory of Movement Analysis and Measurement, Swiss Federal Institute of Technology, Lausanne EPFL, 1015, Switzerland
    IEEE Trans Biomed Eng 54:313-22. 2007
    ..01) to UPDRS with window sizes as short as 5 min. Our study provides evidence that objective, accurate and simultaneous assessment of tremor and bradykinesia can be achieved in free moving PD patients during their daily activities...
  55. ncbi request reprint Prostaglandin D2 synthase and its post-translational modifications in neurological disorders
    Pierre Lescuyer
    Biomedical Proteomics Research Group, Department of Bioinformatics and Structural Biology, Geneva University, Geneva, Switzerland
    Electrophoresis 26:4563-70. 2005
    ..These findings are consistent with PGDS being altered in some neurological diseases and provide new opportunities for clinical applications...
  56. ncbi request reprint Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's disease
    Selma Aybek
    Service de Neurologie, CHUV, Lausanne, Switzerland
    Mov Disord 22:974-81. 2007
    ..These observations suggest dementia being secondary to the natural evolution of PD rather than a direct effect of STN-DBS...
  57. ncbi request reprint Expanding the phenotype of fragile X-associated tremor/ataxia syndrome: a new female case
    Judit Horvath
    Mov Disord 22:1677-8. 2007
  58. ncbi request reprint Compulsive singing: another aspect of punding in Parkinson's disease
    Christophe Bonvin
    Department of Neurology, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
    Ann Neurol 62:525-8. 2007
    ..Sharing many features with punding, this singing behavior is proposed as a distinct manifestation of the dopamine dysregulation syndrome in Parkinson's disease...
  59. ncbi request reprint PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke
    Laure Allard
    Biomedical Proteomics Research Group, Department of Structural Biology and Bioinformatics, Medical and University Center, Geneva, Switzerland
    Clin Chem 51:2043-51. 2005
    ....
  60. ncbi request reprint Truncated cystatin C in cerebrospiral fluid: Technical [corrected] artefact or biological process?
    Odile Carrette
    Biomedical Proteomics Research Group, Geneva University Hospital and Medical School, 1 rue Michel Servet, CH 1211 Geneva 4, Switzerland
    Proteomics 5:3060-5. 2005
    ..These results stress the importance of optimal preanalytical storage conditions of any sample prior to proteomics studies...
  61. ncbi request reprint Ambulatory monitoring of physical activities in patients with Parkinson's disease
    Arash Salarian
    Laboratory of Movement Analysis and Measurement LMAM, Ecole Polytechnique Federale de Lausanne EPFL, STI LMAM, ELG 239, Lausanne Vaud 1024, Switzerland
    IEEE Trans Biomed Eng 54:2296-9. 2007
    ..We concluded that our method provides a simple, accurate, and effective means to objectively quantify physical activities in both normal and PD patients and may prove useful to assess the level of motor functions in the latter...
  62. doi request reprint Phantosmias and Parkinson disease
    Basile N Landis
    Department of Neurology, Geneva University Hospitals, 1211 Geneva 14, Switzerland
    Arch Neurol 65:1237-9. 2008
    ..Impaired olfaction is a common, nonmotor manifestation of Parkinson disease (PD). However, to our knowledge, qualitative olfactory disturbances, such as odor distortions, have not been extensively reported in this condition...